These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2156276)
1. Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients. Golden RN; Hsiao JK; Lane E; Ekstrom D; Rogers S; Hicks R; Potter WZ Psychiatry Res; 1990 Jan; 31(1):39-47. PubMed ID: 2156276 [TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects. Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933 [TBL] [Abstract][Full Text] [Related]
3. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity. Lykouras L; Markianos M; Hatzimanolis Y Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381 [TBL] [Abstract][Full Text] [Related]
4. Acute effect of intravenous clomipramine upon sleep-related hormone secretion in depressed outpatients and healthy control subjects. Jarrett DB; Pollock B; Miewald JM; Kupfer DJ Biol Psychiatry; 1991 Jan; 29(1):3-14. PubMed ID: 2001445 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451 [TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression. Depressed vs normal children. Ryan ND; Birmaher B; Perel JM; Dahl RE; Meyer V; al-Shabbout M; Iyengar S; Puig-Antich J Arch Gen Psychiatry; 1992 Nov; 49(11):843-51. PubMed ID: 1444721 [TBL] [Abstract][Full Text] [Related]
7. Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism. George DT; Nutt DJ; Rawlings RR; Phillips MJ; Eckardt MJ; Potter WZ; Linnoila M Biol Psychiatry; 1995 Jan; 37(2):112-9. PubMed ID: 7718674 [TBL] [Abstract][Full Text] [Related]
8. Abnormal neuroendocrine responsivity to clomipramine in depression. Golden RN; Ruegg R; Brown TM; Haggerty J; Garbutt JC; Pedersen CA; Evans DL Psychopharmacol Bull; 1990; 26(3):317-20. PubMed ID: 2125736 [TBL] [Abstract][Full Text] [Related]
9. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls. Lucey JV; O'Keane V; Butcher G; Clare AW; Dinan TG Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339 [TBL] [Abstract][Full Text] [Related]
10. Immediate effects of intravenous clomipramine on sleep and sleep-related secretion in depressed patients. Kupfer DJ; Pollock BG; Perel JM; Jarrett DB; McEachran AB; Miewald JM Psychiatry Res; 1991 Mar; 36(3):279-89. PubMed ID: 2062969 [TBL] [Abstract][Full Text] [Related]
11. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course. Markianos M; Hatzimanolis J; Lykouras L Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):172-6. PubMed ID: 12242578 [TBL] [Abstract][Full Text] [Related]
12. Responses to mCPP stimulation in depressed patients. Thakore JH Am J Psychiatry; 1995 Dec; 152(12):1833-4; author reply 1834-5. PubMed ID: 8526261 [No Abstract] [Full Text] [Related]
13. Sex-linked differences in cortisol, ACTH and prolactin responses to 5-hydroxy-tryptophan in healthy controls and minor and major depressed patients. Maes M; Vandewoude M; Schotte C; Maes L; Martin M; Blockx P Acta Psychiatr Scand; 1989 Dec; 80(6):584-90. PubMed ID: 2559587 [TBL] [Abstract][Full Text] [Related]
14. Responses to mCPP stimulation in depressed patients. Pitchot W; Ansseau M; Gonzalez Moreno A; Hansenne M Am J Psychiatry; 1995 Dec; 152(12):1834; author reply 1834-5. PubMed ID: 8526262 [No Abstract] [Full Text] [Related]
15. Hormone responses to fenfluramine and placebo challenge in endogenous depression. Lichtenberg P; Shapira B; Gillon D; Kindler S; Cooper TB; Newman ME; Lerer B Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069 [TBL] [Abstract][Full Text] [Related]
16. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects. Meltzer HY; Maes M Biol Psychiatry; 1994 Mar; 35(5):316-23. PubMed ID: 8011800 [TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone. Markianos M; Hatzimanolis J; Lykouras L Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043 [TBL] [Abstract][Full Text] [Related]
18. Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis. Cordes J; Larisch R; Henning U; Thünker J; Werner C; Orozco G; Mayoral F; Rivas F; Auburger G; Tosch M; Rietschel M; Gaebel W; Müller HW; Klimke A Depress Anxiety; 2009; 26(8):E111-9. PubMed ID: 19288582 [TBL] [Abstract][Full Text] [Related]
19. Decreased 5-HT-mediated prolactin release in major depression. Anderson IM; Ware CJ; da Roza Davis JM; Cowen PJ Br J Psychiatry; 1992 Mar; 160():372-8. PubMed ID: 1562864 [TBL] [Abstract][Full Text] [Related]
20. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients. Weizman A; Mark M; Gil-Ad I; Tyano S; Laron Z Clin Neuropharmacol; 1988 Jun; 11(3):250-6. PubMed ID: 2969772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]